1. Rios-Doria, J., Day, K.C., Kuefer, R., Rashid, M.G. and Day, M.L. Calpain-mediated Inactivation of E-cadherin in Prostate and Mammary Epithelial Cells. Journal of Biological Chemistry. 278(2):1372-9. 2003.

2. Kuefer R, Hofer MD, Gschwend JE, Pienta KJ, Sanda MG, Chinnaiyan AM, Rubin MA and Day ML. The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer. Clin. Cancer Res. 9(17):6447-52. 2003.

3. Rios-Doria J, Kuefer R, Ethier SP, and Day ML. Cleavage and activation of b-catenin by calpain in prostate and mammary tumor cells. Cancer Res. 2004 Oct 15;64(20):7237-40.

4. Kuefer R., Zorn C., Hoefer M., Rubin M. and Day ML. Assessment of a fragment of E- cadherin as a serum biomarker with predictive value for prostate cancer. Br J Cancer. June 6;92(11):2018-23. 2005.

5. Kuefer R. Day KC, Kleer C and Day ML. The ADAM15 Disintegrin is Associated with Aggressive Prostate and Breast Cancer. In Press Neoplasia .

1. Rios-Doria, J., Day, K.C., Kuefer, R., Rashid, M.G. and Day, M.L. Calpain-mediated Inactivation of E-cadherin in Prostate and Mammary Epithelial Cells. Journal of Biological Chemistry. 278(2):1372-9. 2003.

2. Rios-Doria J, Kuefer R, Ethier SP, and Day ML. Cleavage and activation of b-catenin by calpain in prostate and mammary tumor cells. Cancer Res. 2004 Oct 15;64(20):7237-40.

3. Rios-Doria J and Day ML. Truncated E-cadherin potentiates cell death in prostate epithelial cells. The Prostate. 2005 May 15;63(3):259-68

1. Day, K.C., McCabe, M.T., Zhao, X., Wang, YZ., Davis, J.N., Phillips, J., Von Geldern, M., Ried, T., KuKuruga, M.A., Cunha, G.R., Hayward, S.W., and Day, M.L.: Homozygous Disruption of the Retinblastoma Gene Alters Cell Cycle and Growth Kinetics but does not Influence Prostatic Differentiation or Morphogenesis. Journal of Biological Chemistry. 2002. 277(46): 44475-44484.

2. McCabe MT, Azih O. and Day ML. Rb-Independent Growth Arrest and Transcriptional Regulation of E2F Target Genes. Neoplasia Feb;7(2):141-51. 2005.

3. Davis JN, McCabe MT Hayward, SW and Day ML. The Regulation of COX-2 Expression and
Function by E2F1 in Prostate Epithelium. Cancer Research May 1;65(9):3633-42. 2005.

4. McCabe MT, Davis JN, and Day ML. Regulation of the DNA Methylation and Gene Silencing
Through the pRb/E2F1 Pathway. Cancer Research May 1;65(9):3624-32. 2005.

5. McCabe MT, J.A. Low, M.J. Imperiale, K.J. Wojno, and Day ML. Inhibition of DNA methyltransferase activity prevents tumor progression in a mouse model of prostate cancer. Cancer Research. 1;66(1):385-92. 2006.

6. McCabe MT, J.A. Low, M.J. Imperiale, and Day ML. Human Polyomavirus BKV Transcriptionally Activates DNA Methyltransferase 1 Through the pRb/E2F Pathway. In Press Oncogene.

1. Davis JN. and Day M.L. The Convergence of Hormone Regulation and Cell Cycle in Prostate Physiology and Prostate Tumorigenesis. Molecular Biotechnology. 22(2):129-38. 2002.

2. Day, K.C., McCabe, M.T., Zhao, X., Wang, YZ., Davis, J.N., Phillips, J., Von Geldern, M., Ried, T., KuKuruga, M.A., Cunha, G.R., Hayward, S.W., and Day, M.L.: Homozygous Disruption of the Retinblastoma Gene Alters Cell Cycle and Growth Kinetics but does not Influence Prostatic Differentiation or Morphogenesis. Journal of Biological Chemistry. 2002. 277(46): 44475-44484.

3. Davis JN, McCabe MT Hayward, SW and Day ML. The Regulation of COX-2 Expression and
Function by E2F1 in Prostate Epithelium. Cancer Research May 1;65(9):3633-42. 2005.

4. McCabe MT, Davis JN, and Day ML. Regulation of the DNA Methylation and Gene Silencing
Through the pRb/E2F1 Pathway. Cancer Research May 1;65(9):3624-32. 2005.